Why Sun Life (SLF) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.
While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.
Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
Founded in 1865 and based in Toronto, Canada, Sun Life is the third largest insurer in Canada. The company is well diversified by geography and product, providing protection and wealth management products and services to individual and group customers worldwide, including in Canada, the United States, United Kingdom, Ireland, Hong Kong , the Philippines , Japan , Indonesia , India , China , Australia , Singapore , Vietnam , Malaysia and Bermuda.
SLF boasts a Momentum Style Score of B and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating. Shares of Sun Life has seen some interesting price action recently; the stock is up 4.1% over the past one week and up 11.4% over the past four weeks. And in the last one-year period, SLF has gained 23.9%. As for the stock's trading volume, 461,615.94 shares on average were traded over the last 20 days.
Momentum investors don't just pay attention to price changes; positive earnings play a crucial role, too. Three analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.04 to $5.21 per share. SLF boasts an average earnings surprise of 2.5%.
SLF should be on investors' short list because of its impressive earnings fundamentals, a good Zacks Rank, and strong Momentum and VGM Style Scores.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sun Life Financial Inc. (SLF) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 hours ago
- Yahoo
Disney Share Prices Jumped — Should You Invest Now?
Walt Disney Co. stock prices have continued to climb following a better-than-expected earnings report in the beginning of May 2025. Stuck at under $100 since March 2025, the stock jumped to more than $112 in early May. It's hovering near its 52-week high of more than $118, and still has room for growth. Read More: Trending Now: Zacks Investment Research gave Disney a grade of 'A' for growth and momentum scores, and 'B' for value. Perhaps it would have been smarter to buy Disney stock in late 2024 or early 2025 if you were looking for value pricing. However, there's still plenty of room for growth. For instance, Rosenblatt Securities raised its price target on Disney from $135 to $140 and rated the stock a 'buy now,' according to Marketbeat. Several other analysts, including UBS Group, Loop Capital and The Goldman Sachs Group also gave Disney buy ratings. A solid earnings statement and the announcement of a new theme park and resort in Abu Dhabi, United Arab Emirates, bolstered Disney stock prices. Revenue increased 7% in the second fiscal quarter, which ended in March 2025. Income before taxes also increased from less than $1 billion to $3.1 billion. Disney+ gained 1.4 million subscribers since the prior quarter. Explore Next: It's no surprise that, in spite of heated competition from Universal's new Epic Universe theme park minutes from Walt Disney World Resort, Disney stock is starting to rise as summer approaches. 'It's a seasonal thing; summertime is always good for Disney,' David Capablanca, Miami native, finance expert, and host of The Friendly Bear podcast said. While it could be school breaks and family vacations driving Disney, the entertainment company also has a solid history and foundation that long-term investors like. 'Disney stock is… something to hold long term,' Capablanca said. 'The entertainment they offer is timeless. They've got a whole catalog of history.' Not every expert called Disney a buy or hold, however. 'Before getting too excited about recent gains, let's remember that Disney has had a lost decade, with the stock trading around the same as it was in 2015,' Vince Stanzione, CEO and founder at First Information, said. He added that even with a strong global economy, Disney has struggled. 'If we are going into a slower economy and a possible recession as I believe we are, I really don't see Disney stock offering any value.' Will a Disney investment earn the same kind of 1350% return Stanzione said Netflix delivered in the past decade? Probably not. But many retail investors buy Disney to own a piece of the company they love. In turn, their portfolio benefits from the addition of a low-risk, slow-growth, dividend-earning stock. Whether you buy Disney or not depends on what you're looking for and how you analyze the numbers. Some experts prefer to focus on the inevitable competition and tailwinds, while others adopt a worry-free philosophy toward the company and choose to focus on the positive earnings in 2025. 'They're a timeless kind of organization [and] very low risk,' Capablanca said. 'As the overall market keeps breaking out, it's going to help Disney maintain an upward trajectory over the long term. We're heading toward all-time highs, and a rising tide lifts all boats.' More From GOBankingRates Mark Cuban Says Trump's Executive Order To Lower Medication Costs Has a 'Real Shot' -- Here's Why This article originally appeared on Disney Share Prices Jumped — Should You Invest Now? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum. Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time. AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmaceutical companies in the world. AstraZeneca was formed on Apr 6, 1999, through the merger of Sweden's Astra AB and UK's Zeneca Group plc. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include CVRM (cardiovascular, renal and metabolism), Respiratory & Immunology (R&I), Oncology, Rare Diseases, Vaccines and Other. AZN sits at a Zacks Rank #3 (Hold), holds a Growth Style Score of B, and has a VGM Score of A. Earnings and sales are forecasted to increase 9.3% and 6.7% year-over-year, respectively. Two analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, while the Zacks Consensus Estimate has increased $0 to $4.49 per share. AZN also boasts an average earnings surprise of 4.2%. On a historic basis, Astrazeneca has generated cash flow growth of 18.6%, and is expected to report cash flow expansion of 16.7% this year. Investors should take the time to consider AZN for their portfolios due to its solid Zacks Rank rating, notable growth metrics, and impressive Growth and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Lemonade (LMND) Reports Q1 Earnings: What Key Metrics Have to Say
Lemonade (LMND) reported $151.2 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 27%. EPS of -$0.86 for the same period compares to -$0.67 a year ago. The reported revenue represents a surprise of +5.05% over the Zacks Consensus Estimate of $143.93 million. With the consensus EPS estimate being -$0.94, the EPS surprise was +8.51%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Lemonade performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: In force premium (end of period): $1.01 billion compared to the $999.35 million average estimate based on four analysts. Premium per Customer (end of period): $396 versus $394.15 estimated by four analysts on average. Customers (end of period): 2,545,496 versus the four-analyst average estimate of 2,535,658. Net loss ratio: 82% versus the four-analyst average estimate of 89%. Gross loss ratio: 78% compared to the 80.8% average estimate based on four analysts. Net investment income: $9.50 million versus the four-analyst average estimate of $8.45 million. The reported number represents a year-over-year change of +25%. Ceding commission income: $26.90 million versus $22.06 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +28.1% change. Commission income: $10.50 million versus the four-analyst average estimate of $8.02 million. The reported number represents a year-over-year change of +72.1%. Net earned premium: $104.30 million compared to the $105.18 million average estimate based on four analysts. The reported number represents a change of +23.6% year over year. View all Key Company Metrics for Lemonade here>>>Shares of Lemonade have returned +6.7% over the past month versus the Zacks S&P 500 composite's +11.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lemonade, Inc. (LMND) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
